Khagendra Dahal
Overview
Explore the profile of Khagendra Dahal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shakir A, Khater J, Iqbal F, Ware E, Mina G, Dahal K, et al.
Am J Cardiovasc Drugs
. 2025 Feb;
PMID: 39966253
Background: Patients with adult congenital heart disease (CHD) have various indications for anticoagulation (e.g., presence of Fontan circuit, atrial fibrillation due to surgical scar). Guidelines recommend vitamin K antagonists (VKA)...
2.
Kansakar S, Qureshi W, Sharma N, Shrestha D, Shtembari J, Shetty V, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941512
There are limited data on the impact of right heart failure (RHF) on patients undergoing transcatheter aortic valve implantation (TAVI). We investigated the mortality, in-hospital complications, length of stay, and...
3.
Dahal K, Lee J
J Cardiothorac Vasc Anesth
. 2024 Aug;
38(11):2817-2818.
PMID: 39122643
No abstract available.
4.
Rheaume B, Adeel M, Dahal K, Lee J
Yonsei Med J
. 2024 Jul;
65(8):488-491.
PMID: 39048325
Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events; however, many patients with AF are noncompliant with medication regimens, which increases said risk substantially. Suboptimal health literacy...
5.
Rai V, Iglesias J, Bossard M, Dahal K, Chang C, Tomaniak M
Front Cardiovasc Med
. 2024 Jun;
11:1437555.
PMID: 38903963
No abstract available.
6.
Mathew Kalathil R, Machanahalli Balakrishna A, El-Shaer A, Goldsweig A, Dahal K, Vallabhajosyula S, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2024 May;
8(3):276-278.
PMID: 38813254
Coronary artery disease is the most common cause of heart failure, which is the leading cause of cardiovascular-related death worldwide. There are insufficient data to make strong recommendations for percutaneous...
7.
Abusnina W, Machanahalli Balakrishna A, Ismayl M, Latif A, Mostafa M, Al-Abdouh A, et al.
Int J Cardiol Heart Vasc
. 2022 Dec;
43:101156.
PMID: 36471671
Femoral access is the gold standard for transcatheter aortic valve replacement (TAVR). Safe alternative access, that represents about 15 % of TAVR cases, remains important for patients without adequate transfemoral...
8.
Abusnina W, Ismayl M, Al-Abdouh A, Ganesan V, Mostafa M, Hallak O, et al.
Shock
. 2022 Nov;
58(5):349-357.
PMID: 36445229
Background: Cardiogenic shock (CS) carries high mortality. The roles of specific mechanical circulatory support (MCS) systems are unclear. We compared the clinical outcomes of Impella versus extracorporal membrane oxygenation (ECMO)...
9.
Abusnina W, Mostafa M, Al-Abdouh A, Radaideh Q, Ismayl M, Alam M, et al.
Front Cardiovasc Med
. 2022 Oct;
9:946027.
PMID: 36204563
Background: Severely calcified coronary lesions with reduced left ventricular (LV) function result in worse outcomes. Atherectomy is used in treating such lesions when technically feasible. However, there is limited data...
10.
Radaideh Q, Abusnina W, Ponamgi S, Al-Abdouh A, Aboeata A, Kanmanthareddy A, et al.
Am J Cardiol
. 2022 Aug;
180:165-166.
PMID: 35945039
No abstract available.